Arena Pharmaceuticals, Inc. Deferred Revenue Recognized
Arena Pharmaceuticals, Inc. reported Deferred Revenue Recognized of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-02-23
- Arena Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Arena Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2019 was $5.00M, a 150.00% increase from fiscal 2018.
- Arena Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2018 was $2.00M, a 83.33% decline from fiscal 2017.
- Arena Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2017 was $12.00M.
| Period end | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-23 |
| 2019-12-31 | $5.00M 10-K · filed 2021-02-23 |
| 2018-12-31 | $2.00M 10-K · filed 2021-02-23 |
| 2017-12-31 | $12.00M 10-K · filed 2020-02-27 |